drugset / Trial / NCT02767245

Thiamine Supplement in Patients With Severe Hyperthyroidism

NCT02767245

Completed 12 enrolled Ramathibodi Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Thyrotoxicosis is a hypermetabolic state in which there is increased utilization of thiamine. Thiamine deficiency has been observed in association with hyperthyroidism. Several studies documented that thiamine treatment could improve signs and symptoms of congestive heart failure, or even improve left ventricular ejection fraction in patients without thyrotoxicosis. This pilot study aims to evaluate prevalence of thiamine deficiency and assess improvement of cardiovascular function after receiving thiamine supplement in thyrotoxic patients.

Timeline

Start
2014-01
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Thiamine Other / unclassified 100 mg Intravenous

Indications